MicroRNA-29 is an essential regulator of brain maturation through regulation of CH methylation.
Abstract
Although embryonic brain development and neurodegeneration have received considerable
attention, the events that govern postnatal brain maturation are less understood.
Here, we identify the miR-29 family to be strikingly induced during the late stages
of brain maturation. Brain maturation is associated with a transient, postnatal period
of de novo non-CG (CH) DNA methylation mediated by DNMT3A. We examine whether an important
function of miR-29 during brain maturation is to restrict the period of CH methylation
via its targeting of Dnmt3a. Deletion of miR-29 in the brain, or knockin mutations
preventing miR-29 to specifically target Dnmt3a, result in increased DNMT3A expression,
higher CH methylation, and repression of genes associated with neuronal activity and
neuropsychiatric disorders. These mouse models also develop neurological deficits
and premature lethality. Our results identify an essential role for miR-29 in restricting
CH methylation in the brain and illustrate the importance of CH methylation regulation
for normal brain maturation.
Type
Journal articleSubject
CH methylationDNMT3A
MeCP2
autism
epilepsy
miR-29
miRNA
neurodevelopmental disorders
non-CG methylation
seizures
Permalink
https://hdl.handle.net/10161/23294Published Version (Please cite this version)
10.1016/j.celrep.2021.108946Publication Info
Swahari, Vijay; Nakamura, Ayumi; Hollville, Emilie; Stroud, Hume; Simon, Jeremy M;
Ptacek, Travis S; ... Deshmukh, Mohanish (2021). MicroRNA-29 is an essential regulator of brain maturation through regulation of CH
methylation. Cell reports, 35(1). pp. 108946. 10.1016/j.celrep.2021.108946. Retrieved from https://hdl.handle.net/10161/23294.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
You-Wen He
Professor of Integrative Immunobiology
We study T cell biology in health and disease. Our current study is divided into two
parts. Part I is to investigate T lymphocyte-mediated anti-caner immunity. We have
found that host complement inhibits the cytokine IL-10 production in CD8+ tumor infiltrating
lymphocytes through complement receptors C3aR and C5aR. Complement-deficient animals
are resistant to tumor development in a T cell- and IL-10-dependent manner. CD8+ tumor
infiltrating T cells express IL-10 when compl

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info